Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Azari

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Urologic Oncology|March 13, 2024
Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastasesVincent E Xu, Ryan M Antar, Luca Bertozzi, et al.
Current Urology Reports|January 14, 2026
Beyond Sterility: the Urinary Microbiome in Bladder Cancer Carcinogenesis and TreatmentStephanie Aron, Margaret Meagher, Sarah Azari, et al.
Clinical Genitourinary Cancer|October 17, 2024
Analysis of Neoadjuvant Chemotherapy Utilization, Pathologic Response, and Overall Survival in Upper Tract Urothelial CarcinomaVincent E Xu, Oluwafolajimi Adesanya, Sarah Azari, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder CancerRyan M Antar, Vincent E Xu, Oluwafolajimi Adesanya, et al.
Translational Andrology and Urology|September 16, 2024
Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancerRyan M Antar, Vincent E Xu, Christian M Farag, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Urologic Oncology|March 13, 2024
Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastasesVincent E Xu, Ryan M Antar, Luca Bertozzi, et al.
Current Urology Reports|January 14, 2026
Beyond Sterility: the Urinary Microbiome in Bladder Cancer Carcinogenesis and TreatmentStephanie Aron, Margaret Meagher, Sarah Azari, et al.
Clinical Genitourinary Cancer|October 17, 2024
Analysis of Neoadjuvant Chemotherapy Utilization, Pathologic Response, and Overall Survival in Upper Tract Urothelial CarcinomaVincent E Xu, Oluwafolajimi Adesanya, Sarah Azari, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder CancerRyan M Antar, Vincent E Xu, Oluwafolajimi Adesanya, et al.
Translational Andrology and Urology|September 16, 2024
Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancerRyan M Antar, Vincent E Xu, Christian M Farag, et al.
Pageof 2